David Patience - 15 May 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Financial Officer
Signature: /s/ David Patience
Issuer symbol: AXDX
Transactions as of: 15 May 2023
Net transactions value: -$843
Form type: 4
Filing time: 16 May 2023, 17:38:18 UTC
Previous filing: 17 Apr 2023
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+3,309	+4.7%	$0.000000	74,392	15 May 2023	Direct	F1
transaction	AXDX	Common Stock	Sale	$843	-1,222	-1.6%	$0.6900	73,170	15 May 2023	Direct	F2
holding	AXDX	Common Stock						7,600	15 May 2023	By Spouse IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-3,309	-13%	$0.000000	23,162	15 May 2023	Common Stock	3,309		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.